Detalhe da pesquisa
1.
Comparative proteome analysis identified CD44 as a possible serum marker for docetaxel resistance in castration-resistant prostate cancer.
J Cell Mol Med
; 26(4): 1332-1337, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34970839
2.
Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas.
Int J Cancer
; 143(7): 1764-1773, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29672836
3.
Matrix metalloproteinase 7, soluble Fas and Fas ligand serum levels for predicting docetaxel resistance and survival in castration-resistant prostate cancer.
BJU Int
; 122(4): 695-704, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29802777
4.
Urachal Carcinoma of the Bladder: Impact of Clinical and Immunohistochemical Parameters on Prognosis.
J Urol
; 195(6): 1690-6, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26678957
5.
[Current diagnostic and treatment strategies for urachal cancer]. / Az urachuscarcinoma aktuális diagnosztikai és kezelési lehetoségei.
Orv Hetil
; 164(16): 602-609, 2023 Apr 23.
Artigo
em Húngaro
| MEDLINE | ID: mdl-37087728
6.
Efficacy of immune checkpoint inhibitor therapy for advanced urothelial carcinoma in real-life clinical practice: results of a multicentric, retrospective study.
Sci Rep
; 13(1): 17378, 2023 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37833455
7.
Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas.
Cancer Med
; 12(7): 9041-9054, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36670542
8.
High Serum PD-L1 Levels Are Associated with Poor Survival in Urothelial Cancer Patients Treated with Chemotherapy and Immune Checkpoint Inhibitor Therapy.
Cancers (Basel)
; 13(11)2021 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34067347
9.
Characteristics of bladder recurrence after radical nephroureterectomy in upper urinary tract cancer / A húgyhólyag-recidíva jellemzoi felso üregrendszeri daganatos betegekben radikális ureteronephrectomia után
Orv Hetil
; 161(21): 881-888, 2020 05.
Artigo
em Húngaro
| MEDLINE | ID: mdl-32427573
10.
Soluble Syndecan-1 Levels Are Associated with Survival in Platinum-Treated Bladder Cancer Patients.
Diagnostics (Basel)
; 10(11)2020 Oct 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33114033
11.
Prevalence of APC and PTEN Alterations in Urachal Cancer.
Pathol Oncol Res
; 26(4): 2773-2781, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32754865
12.
Validation of survivin and HMGA2 as biomarkers for cisplatin resistance in bladder cancer.
Urol Oncol
; 37(11): 810.e7-810.e15, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31053526
13.
Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data.
Dis Markers
; 2018: 7308168, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29721106
14.
Circulating syndecan-1 is associated with chemotherapy-resistance in castration-resistant prostate cancer.
Urol Oncol
; 36(6): 312.e9-312.e15, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29628317
15.
Why are upper tract urothelial carcinoma two different diseases?
Transl Androl Urol
; 5(5): 636-647, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27785420
16.
Clinical, prognostic, and therapeutic aspects of urachal carcinoma-A comprehensive review with meta-analysis of 1,010 cases.
Urol Oncol
; 34(9): 388-98, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27267737
17.
Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: Occurence and prognostic significance.
Oncotarget
; 7(26): 39293-39301, 2016 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27283768